<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0052)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/ -->
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="brjclinpharm"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC2686068/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="./PMC2686068_files/jig.min.css"><script type="text/javascript" src="./PMC2686068_files/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="British Journal of Clinical Pharmacology"><meta name="citation_title" content="Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects"><meta name="citation_authors" content="Rajesh Krishna, Amit Garg, Bo Jin, Sara Sadeghi Keshavarz, Frederick A Bieberdorf, Jeffrey Chodakewitz, John A Wagner"><meta name="citation_date" content="May 2009"><meta name="citation_issue" content="5"><meta name="citation_volume" content="67"><meta name="citation_firstpage" content="520"><meta name="citation_doi" content="10.1111/j.1365-2125.2009.03385.x"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2686068/?report=abstract"><meta name="citation_pmid" content="19552746"><meta name="DC.Title" content="Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Wiley-Blackwell"><meta name="DC.Contributor" content="Rajesh Krishna"><meta name="DC.Contributor" content="Amit Garg"><meta name="DC.Contributor" content="Bo Jin"><meta name="DC.Contributor" content="Sara Sadeghi Keshavarz"><meta name="DC.Contributor" content="Frederick A Bieberdorf"><meta name="DC.Contributor" content="Jeffrey Chodakewitz"><meta name="DC.Contributor" content="John A Wagner"><meta name="DC.Date" content="2009 May"><meta name="DC.Identifier" content="10.1111/j.1365-2125.2009.03385.x"><meta name="DC.Language" content="en"><meta property="og:title" content="Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects"><meta property="og:type" content="article"><meta property="og:description" content="Anacetrapib is an orally active, potent inhibitor of cholesteryl ester transfer protein (CETP), which is in development for the treatment of dyslipidaemia. Because of the likely use of anacetrapib with hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, ..."><meta property="og:url" content="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="./PMC2686068_files/pmc.min.css" type="text/css"><link rel="stylesheet" href="./PMC2686068_files/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="./PMC2686068_files/common.min.js">//</script><script type="text/javascript" src="./PMC2686068_files/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:&#39;/pmc/utils/ctxp/&#39;"><script type="text/javascript" src="./PMC2686068_files/jquery.citationexporter.js">//</script><link rel="stylesheet" href="./PMC2686068_files/citationexporter.css" type="text/css"><script type="text/javascript" src="./PMC2686068_files/MathJax.js"></script><script type="text/javascript" src="./PMC2686068_files/large-obj-scrollbars.min.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-brjclinpharm.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><link rel="alternate" type="application/epub+zip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/epub/"><link rel="alternate" type="application/pdf" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/pdf/bcp0067-0520.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="http://www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="F4FC048C76C26B01000000000096EF43"><link type="text/css" rel="stylesheet" href="./PMC2686068_files/3855312.css"><link type="text/css" rel="stylesheet" href="./PMC2686068_files/3929378.css" media="print"><style type="text/css" media="print">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('http://www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=pmc&ncbi_db=pmc&ncbi_pcid=%2Farticles%2FPMC2686068%2F&ncbi_pdid=article&ncbi_phid=F4FC048C76C26B01000000000096EF43'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-jig-5"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="http://www.ncbi.nlm.nih.gov/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="./PMC2686068_files/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a><ul id="resources-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/" tabindex="-1" role="menuitem">All Resources</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#chemicals-bioassays" tabindex="-1" role="menuitem" class="expandRight">Chemicals &amp; Bioassays</a><ul class="actual-resources-submenu chemicals-bioassays ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcassay" title=" Contributed bioactivity data for PubChem Substances " tabindex="-1" role="menuitem">PubChem BioAssay</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pccompound" title=" Unique, standardized chemical structures " tabindex="-1" role="menuitem">PubChem Compound</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcsubstance" title=" Provides information on the biological activities of small molecules. " tabindex="-1" role="menuitem">PubChem Substance</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/" tabindex="-1" role="menuitem">All Chemicals &amp; Bioassays Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#dna-rna" tabindex="-1" role="menuitem" class="expandRight">DNA &amp; RNA</a><ul class="actual-resources-submenu dna-rna ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/" title=" DNA and RNA sequences submitted to NCBI " tabindex="-1" role="menuitem">GenBank</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/" tabindex="-1" role="menuitem">All DNA &amp; RNA Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#data-software" tabindex="-1" role="menuitem" class="expandRight">Data &amp; Software</a><ul class="actual-resources-submenu data-software ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/" tabindex="-1" role="menuitem">All Data &amp; Software Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#domains-structures" tabindex="-1" role="menuitem" class="expandRight">Domains &amp; Structures</a><ul class="actual-resources-submenu domains-structures ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/structure/" title=" Database of 3D macromolecular structures derived from PDB " tabindex="-1" role="menuitem">Structure (Molecular Modeling Database)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/" tabindex="-1" role="menuitem">All Domains &amp; Structures Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#genes-expression" tabindex="-1" role="menuitem" class="expandRight">Genes &amp; Expression</a><ul class="actual-resources-submenu genes-expression ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gene" title=" Database of gene loci and associated transcripts and proteins " tabindex="-1" role="menuitem">Gene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geo/" title=" Gene Expression Omnibus (GEO) Database " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Database </a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gds" title=" Curated collections of gene expression data sets " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Datasets</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geoprofiles/" title=" Database of gene expression Profiles for individual sequences " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Profiles</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/" tabindex="-1" role="menuitem">All Genes &amp; Expression Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#genetics-medicine" tabindex="-1" role="menuitem" class="expandRight">Genetics &amp; Medicine</a><ul class="actual-resources-submenu genetics-medicine ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gtr/" title=" Detailed information about genetic tests and labs " tabindex="-1" role="menuitem">Genetic Testing Registry</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/" tabindex="-1" role="menuitem">All Genetics &amp; Medicine Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#genomes-maps" tabindex="-1" role="menuitem" class="expandRight">Genomes &amp; Maps</a><ul class="actual-resources-submenu genomes-maps ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sites/genome" title=" Curated genomic DNA sequences " tabindex="-1" role="menuitem">Genome</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/bioproject/" title=" Central status pages for genome sequencing projects " tabindex="-1" role="menuitem">Genome Project</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/" tabindex="-1" role="menuitem">All Genomes &amp; Maps Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#homology" tabindex="-1" role="menuitem" class="expandRight">Homology</a><ul class="actual-resources-submenu homology ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/" tabindex="-1" role="menuitem">All Homology Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#literature" tabindex="-1" role="menuitem" class="expandRight">Literature</a><ul class="actual-resources-submenu literature ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nlmcatalog/journals" title=" Information on journals cited by NCBI records " tabindex="-1" role="menuitem">Journals in NCBI Databases</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mesh" title=" Controlled vocabulary for MEDLINE " tabindex="-1" role="menuitem">MeSH Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/" title=" Reviews of clinical effectiveness research " tabindex="-1" role="menuitem">PubMed Health</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/" tabindex="-1" role="menuitem">All Literature Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#proteins" tabindex="-1" role="menuitem" class="expandRight">Proteins</a><ul class="actual-resources-submenu proteins ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/protein" title=" Protein sequence data " tabindex="-1" role="menuitem">Protein Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/" tabindex="-1" role="menuitem">All Proteins Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#sequence-analysis" tabindex="-1" role="menuitem" class="expandRight">Sequence Analysis</a><ul class="actual-resources-submenu sequence-analysis ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/" tabindex="-1" role="menuitem">All Sequence Analysis Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#taxonomy" tabindex="-1" role="menuitem" class="expandRight">Taxonomy</a><ul class="actual-resources-submenu taxonomy ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/taxonomy" title=" The NCBI taxonomy tree in Entrez " tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Root" title=" Displays and links Entrez data to each taxonomic node " tabindex="-1" role="menuitem">Taxonomy Browser</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi" title=" Creates custom taxonomic trees " tabindex="-1" role="menuitem">Taxonomy Common Tree</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/" tabindex="-1" role="menuitem">All Taxonomy Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#training-tutorials" tabindex="-1" role="menuitem" class="expandRight">Training &amp; Tutorials</a><ul class="actual-resources-submenu training-tutorials ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/education/" title=" Central page providing links to tutorials and training materials " tabindex="-1" role="menuitem">NCBI Education Page</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/" tabindex="-1" role="menuitem">All Training &amp; Tutorials Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#variation" tabindex="-1" role="menuitem" class="expandRight">Variation</a><ul class="actual-resources-submenu variation ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/snp" title=" Database of nucleotide sequence polymorphisms " tabindex="-1" role="menuitem">Database of Single Nucleotide Polymorphisms (dbSNP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/" tabindex="-1" role="menuitem">All Variation Resources...</a></li></ul></li></ul></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a><ul id="howto-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/#howtos" tabindex="-1" role="menuitem">All How To</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/#howtos" tabindex="-1" role="menuitem">Chemicals &amp; Bioassays</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/#howtos" tabindex="-1" role="menuitem">DNA &amp; RNA</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/#howtos" tabindex="-1" role="menuitem">Data &amp; Software</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/#howtos" tabindex="-1" role="menuitem">Domains &amp; Structures</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/#howtos" tabindex="-1" role="menuitem">Genes &amp; Expression</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/#howtos" tabindex="-1" role="menuitem">Genetics &amp; Medicine</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/#howtos" tabindex="-1" role="menuitem">Genomes &amp; Maps</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/#howtos" tabindex="-1" role="menuitem">Homology</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/#howtos" tabindex="-1" role="menuitem">Literature</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/#howtos" tabindex="-1" role="menuitem">Proteins</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/#howtos" tabindex="-1" role="menuitem">Sequence Analysis</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/#howtos" tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/#howtos" tabindex="-1" role="menuitem">Training &amp; Tutorials</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/#howtos" tabindex="-1" role="menuitem">Variation</a></li></ul></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="http://www.ncbi.nlm.nih.gov/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="http://www.ncbi.nlm.nih.gov/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2686068%2F" id="sign_in">Sign in to NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/signout/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2686068%2F" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="http://www.ncbi.nlm.nih.gov/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="http://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="http://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="http://www.ncbi.nlm.nih.gov/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbook">ToolKitBook</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config="dictionary:&#39;pmc-search-autocomplete&#39;,disableUrl:&#39;NcbiSearchBarAutoComplCtrl&#39;" autocomplete="off" data-sbconfig="ds:&#39;no&#39;,pjs:&#39;no&#39;,afs:&#39;yes&#39;" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" style="visibility: hidden;"><img src="./PMC2686068_files/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/limits/">Limits</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="http://www.ncbi.nlm.nih.gov/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="http://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a></li><li class="archive-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/journals/279/">Br J Clin Pharmacol</a></li><li class="issue-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/issues/179035/">v.67(5); 2009 May</a></li><li class="accid">PMC2686068</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="./PMC2686068_files/logo-brjclinpharm.gif" alt="Logo of brjclinpharm" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher&#39;s site" title="Link to Publisher&#39;s site" shape="default" coords="0,0,499,74" href="http://www.blackwellpublishing.com/journal.asp?ref=0306-5251" target="pmc_ext" ref="reftype=publisher&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden&#39;" id="ui-jig-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit">Br J Clin Pharmacol. 2009 May; 67(5): 520526. </span></div><div>  <span class="doi">doi:&nbsp; <a href="http://dx.doi.org/10.1111%2Fj.1365-2125.2009.03385.x" target="pmc_ext" ref="reftype=other&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1111/j.1365-2125.2009.03385.x</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2686068</span></div></div></div></div></div><h1 class="content-title">Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Krishna%20R%5Bauth%5D">Rajesh Krishna</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Garg%20A%5Bauth%5D">Amit Garg</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Jin%20B%5Bauth%5D">Bo Jin</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Keshavarz%20SS%5Bauth%5D">Sara Sadeghi Keshavarz</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Bieberdorf%20FA%5Bauth%5D">Frederick A Bieberdorf</a>,<sup>1</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chodakewitz%20J%5Bauth%5D">Jeffrey Chodakewitz</a>, and  <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Wagner%20JA%5Bauth%5D">John A Wagner</a></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="id829522_ai" style="display:none"><div class="fm-affl" lang="en">Merck &amp; Co., Inc., Whitehouse Station, NJ, Austin, TX, USA</div><div class="fm-affl" lang="en"><sup>1</sup>CEDRA Clinical Research LLC, Austin, TX, USA</div><div id="cor1">Correspondence Dr Rajesh Krishna, PhD, FCP, Merck Research Laboratories, Mailstop RY34-A500, 126 East Lincoln Avenue, Rahway, NJ 07065-0900, USA. Tel: +1 732 594 1484 Fax: +1 732 594 5405 E-mail: <a href="mailto:dev@null" data-email="moc.kcrem@anhsirk_hsejar" class="oemail">moc.kcrem@anhsirk_hsejar</a></div></div><div class="togglers"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="pmctoggle" rid="id829522_ai">Author information <span></span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="pmctoggle" rid="id829522_an">Article notes <span></span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="pmctoggle" rid="id829522_cpl">Copyright and License information <span></span></a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="id829522_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 Nov 7; Accepted 2009 Feb 1.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="id829522_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright</a> Journal compilation  2009 The British Pharmacological Society</div></div></div><div class="links-box fm-panel whole_rhythm"><div class="small"><div>This article has been <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="__abstractid770149" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-7"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true" id="ui-jig-8">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__abstractid770149title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3>AIMS</h3><p id="__p1" class="p p-first-last">Anacetrapib is an orally active, potent inhibitor of cholesteryl ester transfer protein (CETP), which is in development for the treatment of dyslipidaemia. Because of the likely use of anacetrapib with hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, we aimed to evaluate the potential for a pharmacokinetic interaction with simvastatin.</p></div><div id="__sec2" class="sec"><h3>METHODS</h3><p id="__p2" class="p p-first-last">A randomized, two-period, two-treatment, balanced, open-label, crossover study in 12 healthy subjects was performed. Subjects received simvastatin 40 mg alone or anacetrapib 150 mg co-administered with simvastatin 40 mg, once daily. Both treatments were administered following a low-fat breakfast for 14 days, separated by a wash-out period of at least 14 days. Safety and tolerability, simvastatin and simvastatin acid concentrations, and lipoproteins, were assessed.</p></div><div id="__sec3" class="sec"><h3>RESULTS</h3><p id="__p3" class="p p-first-last">Both treatments were well tolerated. The pharmacokinetics of simvastatin and simvastatin acid were similar with and without anacetrapib administration {AUC<sub>024 h</sub> geometric mean ratio [90% confidence interval (CI)] for simvastatin acid and simvastatin were 1.36 [1.17, 1.57] and 1.30 [1.14, 1.47], respectively} based on the prespecified comparability bounds of (0.50, 2.00). Treatment with simvastatin alone led to a mean (95% CI) % reduction from baseline in low-density lipoprotein-cholesterol (LDL-C) of 36% (27, 46) compared with a reduction of 54% (44, 63) for anacetrapib co-administered with simvastatin.</p></div><div id="__sec4" class="sec sec-last"><h3>CONCLUSIONS</h3><p id="__p4" class="p p-first-last">There appears to be no clinically meaningful effect of anacetrapib on the pharmacokinetic parameters of simvastatin. When co-administered with simvastatin, anacetrapib appeared to exhibit incremental LDL-C-lowering efficacy, due to CETP inhibition. Co-administration of anacetrapib and simvastatin was well tolerated.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">CETP inhibition, LDL-C, simvastatin</span></div></div><div id="__bodyid770780" class="tsec sec headless whole_rhythm"><div class="boxed-text-box whole_rhythm hide-overflow"><div class="sec"><h3>WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT</h3><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
--><li><div>Inhibition of cholesteryl ester transfer protein (CETP) is considered a potential new mechanism for the treatment of dyslipidaemia, for which hydroxy-3-methylglutaryl coenzyme A reductase inhibitors remain a cornerstone of therapy.</div></li><li><div>Clinical studies published to date with other investigational CETP inhibitors, torcetrapib (Pfizer) and dalcetrapib (Roche), have been evaluated in the presence of statins, but it remains unclear whether there is a clinically meaningful interaction between a CETP inhibitor and a statin, and whether the low-density lipoprotein-cholesterol (LDL-C)-lowering effects are additive with the combination.</div></li></ul></div></div><div class="boxed-text-box whole_rhythm hide-overflow"><div class="sec"><h3>WHAT THIS STUDY ADDS</h3><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
--><li><div>This is the first study to show that there is no clinically meaningful effect of anacetrapib on the pharmacokinetic parameters of simvastatin.</div></li><li><div>When co-administered with simvastatin, anacetrapib appeared to exhibit incremental LDL-C-and apolipoprotein (Apo) B-lowering efficacy, due to CETP inhibition, the magnitude of which appears greater than any combination of CETP inhibitor and statin evaluated to date.</div></li><li><div>The study also provides useful insights into the LDL-C-and Apo B-lowering effects when a CETP inhibitor is given in combination with a statin.</div></li></ul></div></div></div><div id="__sec7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-9"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-10">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec7title">Introduction</h2><p id="__p10" class="p p-first">Anacetrapib (MK-0859) is an investigational cholesteryl ester transfer protein (CETP) inhibitor being developed for the treatment of dyslipidaemias including primary hypercholesterolaemia and mixed hyperlipidaemia that increase susceptibility to atherosclerotic cardiovascular disease [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b1" rid="b1" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511254" role="button" aria-expanded="false" aria-haspopup="true">8</a>].</p><p id="__p11">A midazolam clinical study in healthy subjects for the assessment of effects of CYP3A4 with multiple doses of anacetrapib revealed the compound was neither an inducer nor inhibitor of CYP3A4 [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511257" role="button" aria-expanded="false" aria-haspopup="true">8</a>]. Anacetrapib was also not a potent reversible inhibitor of human CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 or 3A4 in human liver microsomal incubations [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511256" role="button" aria-expanded="false" aria-haspopup="true">8</a>]. The potential for concomitant medications in patients with dyslipidaemia is fairly high (e.g. statins), and since CYP3A4 is a common pathway for metabolism of drugs, the assessment of an effect of anacetrapib on CYP3A4 activity could shed light on the extent of interaction between anacetrapib and a hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor. Because of the potential use of anacetrapib with HMG-CoA reductase inhibitors, it was also considered important to understand the extent of lipid-altering effects incrementally in addition to a statin treatment.</p><p id="__p12" class="p p-last">Thus, the primary objective of this study was to investigate and quantify any potential pharmacokinetic interaction between simvastatin and anacetrapib, following multiple oral doses of each, when the drugs are co-administered in the morning following administration of a low-fat meal. A secondary objective was to evaluate the effect on lipids and lipoproteins between the two treatments. Safety and tolerability of treatment with anacetrapib and simvastatin were also assessed.</p></div><div id="__sec8" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-11"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-12">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec8title">Methods</h2><div id="__sec9" class="sec sec-first"><h3>Study participants</h3><p id="__p13" class="p p-first-last">All study participants provided written informed consent prior to enrolment. The protocol was approved by IntegReview Ethical Review Board (Austin, TX, USA) and was conducted in accordance with the guidelines on good clinical practice and with ethical standards for human experimentation established by the Declaration of Helsinki. Healthy male or female subjects of nonreproductive potential, 1850 years old, participated in this study, which was conducted in the USA. Subjects were in good general health according to routine medical history, physical examination, vital signs and laboratory data.</p></div><div id="__sec10" class="sec"><h3>Study design</h3><p id="__p14" class="p p-first">This was an open-label, randomized, two-period, two-treatment, balanced, crossover study in 12 healthy subjects. In Treatment A, subjects received a once daily oral dose of a 40-mg simvastatin tablet (ZOCOR) for 14 days in the morning. In Treatment B, subjects received a once-daily oral dose of 150 mg anacetrapib, as liquid-filled capsules, co-administered with a once-daily oral dose of a 40-mg simvastatin tablet for 14 days in the morning. All doses were administered following a standardized low-fat breakfast, and there was a wash-out of at least 14 days in duration between treatment periods.</p><p id="__p15" class="p p-last">Pharmacokinetic blood samples for simvastatin and simvastatin acid were collected on day 14 of Treatments A and B and predose on days 1, 12, 13 and 14, and measured simultaneously according to a liquid chromatography/tandem mass spectrometry method [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b9" rid="b9" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">9</a>]. Serum samples were collected for the measurement of low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), and the apolipoproteins (Apo) B and A1 predose on day 1 (Treatments A and B) and day 14 (Treatments A and B). Assays for HMG-CoA reductase activity were not performed.</p></div><div id="__sec11" class="sec"><h3>Pharmacokinetic data analysis</h3><p id="__p16" class="p p-first-last">Plasma concentration <em>vs.</em> time data were analysed by noncompartmental pharmacokinetic methods using WinNonlin (Enterprise version 5.0.1; Pharsight Corp., Mountain View, CA, USA) to determine the pharmacokinetic parameter estimates. The actual blood sampling times relative to the dosing times were used for all pharmacokinetic analysis. AUC<sub>0</sub> was calculated using the linear trapezoidal method for ascending concentrations and the log trapezoidal method for descending concentrations. <em>C</em><sub>max</sub> and <em>T</em><sub>max</sub> were obtained by inspection. The elimination rate constant (<sub>z</sub>) was determined by linear regression of the terminal phase of the logarithm of plasma concentration <em>vs.</em> time data. A minimum of three data points were used. The <em>t</em><sub>1/2</sub> was calculated as the ratio of the natural log of 2 and <sub>z</sub>.</p></div><div id="__sec12" class="sec"><h3>Safety and tolerability</h3><p id="__p17" class="p p-first-last">The safety and tolerability of anacetrapib and simvastatin were assessed throughout the study by physical examinations, vital signs, 12-lead ECG, laboratory safety tests (serum sodium, potassium, chloride, bicarbonate, calcium, creatinine, blood urea nitrogen, fasting serum glucose, bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, albumin; haemoglobin, haematocrit, platelet count, white blood cell count, absolute counts of neutrophils, eosinophils, basophils, lymphocytes, monocytes; urinalysis), and adverse experience monitoring.</p></div><div id="__sec13" class="sec sec-last"><h3>Statistical methods</h3><p id="__p18" class="p p-first">One subject discontinued from the study in period 1 and was excluded from analysis.</p><p id="__p19" class="p p-last">The pharmacokinetic parameters for simvastatin acid and simvastatin, AUC<sub>024 h</sub> and <em>C</em><sub>max</sub>, were natural log transformed and evaluated with a linear mixed-effects model with treatment as a fixed effect and subject as a random effect. Mean between-treatment differences and corresponding 90% confidence intervals (CIs) were obtained from the model and exponentiated to obtain geometric mean treatment ratios and CIs. The primary hypothesis was that the AUC<sub>024 h</sub> geometric mean ratio (GMR) of simvastatin and simvastatin acid following multiple oral doses of 40 mg simvastatin (<em>vs.</em> anacetrapib alone) is contained within the interval (0.50, 2.00). Summary statistics have been provided for systolic blood pressure, diastolic blood pressure, LDL-C, HDL-C, Apo A1 and Apo B.</p></div></div><div id="__sec14" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-13"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-14">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec14title">Results</h2><p id="__p20" class="p p-first">Anacetrapib administered in combination with simvastatin was generally well tolerated. There were no serious clinical or laboratory adverse experiences reported and no subject discontinued because of an adverse experience. There were no meaningful changes in blood pressure (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#SD1" rid="SD1" class=" supplementary-material">Table S1</a>). One subject discontinued from the study in period 1, who did not report to the clinical site for dosing and was lost to follow-up.</p><p id="__p21">The pharmacokinetics of simvastatin and simvastatin acid were similar with and without anacetrapib administration (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/table/tbl1/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/figure/fig01/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="fig01" rid-ob="ob-fig01" co-legend-rid="lgnd_fig01"><span>Figure 1</span></a>). Specifically, the key parameter, AUC<sub>024 h</sub> GMR (90% CI) for simvastatin acid and simvastatin were 1.36 (1.17, 1.57) and 1.30 (1.14, 1.47), respectively. Similarly, the <em>C</em><sub>max</sub> GMR (90% CI) for simvastatin acid and simvastatin were 1.26 (1.03, 1.55) and 1.24 (1.01, 1.52), respectively. There were no meaningful differences in <em>T</em><sub>max</sub> or apparent <em>T</em><sub>1/2</sub> between the two treatments for either simvastatin acid or simvastatin. While calculated, the half-life values should be interpreted with caution given reversible metabolism of simvastatin to simvastatin acid.</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="tbl1"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/table/tbl1/" target="table" rid-ob="ob-tbl1" rid-figpopup="tbl1" class="table img_link icnblk_img figpopup"><img alt="Table 1" title="Table 1" class="small-thumb" src="./PMC2686068_files/saved_resource" src-large="/pmc/articles/PMC2686068/table/tbl1/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/table/tbl1/" target="table" rid-figpopup="tbl1" rid-ob="ob-tbl1">Table 1</a></div><!--caption a4--><div><span>Summary of simvastatin acid and simvastatin pharmacokinetic parameters</span></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="fig01" co-legend-rid="lgnd_fig01"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/figure/fig01/" target="figure" rid-figpopup="fig01" rid-ob="ob-fig01"><img src="./PMC2686068_files/bcp0067-0520-f1.gif" class="small-thumb" alt="Figure 1" title="Figure 1" src-large="/pmc/articles/PMC2686068/bin/bcp0067-0520-f1.jpg"></a><div class="icnblk_cntnt" id="lgnd_fig01"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/figure/fig01/" target="figure" rid-figpopup="fig01" rid-ob="ob-fig01">Figure 1</a></div><!--caption a4--><div><span>Plasma concentrationtime profiles for simvastatin acid (A) and simvastatin (B). Treatment A (Simvastatin alone) (); Treatment B (Simvastatin + Anacetrapib) ()</span></div></div></div><p id="__p27" class="p"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/table/tbl2/" target="true" class="fig-table-link table figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a> lists the summary statistics for LDL-C, HDL-C, Apo B and A1 at baseline and on day 14 at 24 h post dose. Treatment with simvastatin alone led to a mean (95% CI) % reduction from baseline in LDL-C of 36% (27, 46) compared with a reduction of 54% (44, 63) for anacetrapib co-administered with simvastatin. The estimated difference (90% CI) (anacetrapib + simvastatin <em>vs.</em> simvastatin alone) in LDL-C mean % change from baseline was therefore 17% (25, 9). Similarly, the estimated differences (90% CI) (anacetrapib + simvastatin <em>vs.</em> simvastatin alone) in other lipoprotein parameters were as follows: HDL-C 85% (66, 105); Apo B 14% (18, 10); and Apo A1, 28% (19, 38).</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="tbl2"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/table/tbl2/" target="table" rid-ob="ob-tbl2" rid-figpopup="tbl2" class="table img_link icnblk_img figpopup"><img alt="Table 2" title="Table 2" class="small-thumb" src="./PMC2686068_files/saved_resource(1)" src-large="/pmc/articles/PMC2686068/table/tbl2/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/table/tbl2/" target="table" rid-figpopup="tbl2" rid-ob="ob-tbl2">Table 2</a></div><!--caption a4--><div><span>Summary of the % change from baseline in lipoproteins</span></div></div></div></div><div id="__sec15" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-15"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-16">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec15title">Discussion</h2><p id="__p30" class="p p-first">The study explored primarily the pharmacokinetic interaction between simvastatin and anacetrapib, as it relates to the effect of anacetrapib on simvastatin pharmacokinetics. Simvastatin is a lactone that is readily hydrolysed <em>in vivo</em> to the corresponding -hydroxyacid, a potent inhibitor of HMG-CoA reductase. <em>In vitro</em> studies have demonstrated that CYP3A4 is the major enzyme system responsible for the metabolism of simvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10" rid="b10" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. Simvastatin is well absorbed (about 6080%) after oral administration, but it undergoes extensive first-pass metabolism by the hepatic CYP3A4 system [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10" rid="b10" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. The bioavailability of active HMG-CoA reductase inhibitors following simvastatin tablets is &lt;5% of the oral dose. Therefore, simvastatin was selected as the statin for this drug interaction study. Although the 80-mg dose of simvastatin is the highest currently approved dose, the recommended usual starting dose is 2040 mg, and 40 mg in patients with high risk for a cardiovascular event [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10" rid="b10" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. Therefore, the study investigated a 40-mg dose of simvastatin with and without anacetrapib. This simvastatin dose was chosen to increase the sensitivity of the potential for a pharmacokinetic interaction of anacetrapib with simvastatin. The anacetrapib dose of 150 mg once daily with a low-fat breakfast evaluated in this study represents a higher end of the therapeutic dose range, which attained pharmacodynamic plateau in patients with dyslipidaemia [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b4" rid="b4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511248" role="button" aria-expanded="false" aria-haspopup="true">4</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b5" rid="b5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511244" role="button" aria-expanded="false" aria-haspopup="true">5</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. A low-fat breakfast was employed since anacetrapib's pharmacokinetics is less variable in this state than with a high-fat breakfast [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b3" rid="b3" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">3</a>]. Simvastatin's absorption is not affected by food, hence not impacted by the low-fat meal given in this study [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10" rid="b10" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. A multiple-dose study design was used where simvastatin and anacetrapib were dosed orally to steady state and the effect of anacetrapib on the plasma levels of simvastatin was studied. A duration of 14 days as multiple oral daily dosing was considered sufficient to achieve pharmacokinetic and pharmacodynamic steady state for each drug [[<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b4" rid="b4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511255" role="button" aria-expanded="false" aria-haspopup="true">4</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b5" rid="b5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511245" role="button" aria-expanded="false" aria-haspopup="true">5</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10" rid="b10" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">10</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b11" rid="b11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511258" role="button" aria-expanded="false" aria-haspopup="true">11</a>].</p><p id="__p31">The result of this study shows that there is no clinically meaningful effect of anacetrapib on the pharmacokinetics of simvastatin (simvastatin acid or simvastatin). This is not unexpected, given data in the literature showing drug interactions with simvastatin were metabolic in nature, as a result of inhibition or induction of the CYP3A enzyme system [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b12" rid="b12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511243" role="button" aria-expanded="false" aria-haspopup="true">12</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b14" rid="b14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511250" role="button" aria-expanded="false" aria-haspopup="true">14</a>]. The lack of clinically meaningful interaction with a sensitive CYP3A substrate such as simvastatin is consistent with the finding that anacetrapib does not induce or inhibit CYP3A [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511252" role="button" aria-expanded="false" aria-haspopup="true">8</a>].</p><p id="__p32">An exploratory objective was to evaluate the pharmacodynamic, particularly the lipid-altering biomarkers, interaction between simvastatin and anacetrapib. Anacetrapib is an investigational CETP inhibitor that has shown significant lipid-altering pharmacodynamic effects in both healthy subjects and in patients with dyslipidaemia, both alone as well as in the presence of atorvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b4" rid="b4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511249" role="button" aria-expanded="false" aria-haspopup="true">4</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b5" rid="b5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511241" role="button" aria-expanded="false" aria-haspopup="true">5</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. Thus, the findings of this 14-day study on the lipoprotein parameters are quite interesting in light of available data on anacetrapib, as monotherapy and in combination with atorvastatin. Anacetrapib has been associated with maximal pharmacodynamic lipid effects in a completed Phase 2b study that resulted in decreases in LDL-C and Apo B of 40 and 30%, respectively, and increases in HDL-C and Apo A-I of 139 and 47%, respectively [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. At the top doses of anacetrapib (150 and 300 mg), the maximal reductions in LDL-C and Apo B were similar to those with atorvastatin 20 mg [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. Moreover, incremental reductions in LDL-C and Apo B were observed when anacetrapib was co-administered with atorvastatin 20 mg. The net result of treatment with anacetrapib and atorvastatin was approximately 70% lowering of LDL-C, approximately 50% lowering of Apo B, and more than doubling of HDL-C in patients with dyslipidaemia [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. Anacetrapib does not meaningfully alter serum total cholesterol or triglycerides, and hence was not measured in the present study. Simvastatin is a highly effective marketed drug for the reduction of LDL-C and triglycerides that acts through competitive inhibition of HMG-CoA reductase, the enzyme that catalyses the rate-limiting step in cholesterol biosynthesis [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10" rid="b10" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. Simvastatin, at a dose of 80 mg per day, effectively reduced LDL-C by 47%, increased HDL-C by 8%, and lowered triglycerides by 24% in hypercholesterolaemic patients in the Upper Dose Comparison Study [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10" rid="b10" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. In the Multicenter Combined Hyperlipidemia Study, simvastatin, when administered either at 40 or 80 mg per day, elicited LDL-C decreases of 2936%, HDL-C increases of 1316%, and triglyceride decreases of 2833% [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10" rid="b10" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">10</a>].</p><p id="__p33">In this study, simvastatin alone reduced LDL-C by 36% and Apo B by 29%, whereas in combination with anacetrapib, LDL-C was reduced by approximately 54% and Apo B by 43%. A 150-mg dose of anacetrapib, administered with a low-fat meal, is predicted to reduce LDL-C by approximately 40%, based on a model relating anacetrapib concentrations with LDL-C. A strictly additive effect would have resulted in a combined LDL-C-lowering effect of about 76%, which is about 22% higher than actually observed with the combination. Although there was still an incremental LDL-C lowering seen with the combination, the relative decrease in LDL-C was lower than what would have been expected as the sum of the effects of two drugs given alone. This is consistent with the findings observed with anacetrapib (10300 mg) and atorvastatin 20 mg in the Phase 2b study, wherein atorvastatin 20 mg reduced LDL-C by approximately 42% and when atorvastatin 20 mg was given with anacetrapib 150 mg, LDL-C was reduced by about 65% [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. In the same study, a 150-mg dose of anacetrapib was associated with LDL-C lowering of approximately 40%, which is about 17% lower than expected if an additive effect was considered. Thus, less than additive LDL-C-lowering effects were seen with two agents of the statin class with anacetrapib. Similar, less than strict additive effects have been observed with torcetrapib, another CETP inhibitor alone and in combination with atorvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b15" rid="b15" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">15</a>].</p><p id="__p34">The exact reason for a lack of an additive effect on the LDL-C-lowering effect is unclear. There have been complex mechanistic pharmacodynamic interactions between statins and nonstatins reported in the literature, depending on the specific mechanism of action of the nonstatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b16" rid="b16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511240" role="button" aria-expanded="false" aria-haspopup="true">16</a>]. Whereas additive or synergistic effects between nonstatin and statins have been observed with ezetemibe [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b14" rid="b14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511239" role="button" aria-expanded="false" aria-haspopup="true">14</a>] and cholestyramine [[<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b11" rid="b11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511247" role="button" aria-expanded="false" aria-haspopup="true">11</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b17" rid="b17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511246" role="button" aria-expanded="false" aria-haspopup="true">17</a>], nonlinear and pharmacologically dependent effects have been observed with gemcabene [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b16" rid="b16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511253" role="button" aria-expanded="false" aria-haspopup="true">16</a>], a discontinued lipid-altering drug. It should be noted that both ezetemibe and cholestyramine have distinctly different mechanisms of LDL-C-lowering effects compared with statins, whereas the exact mechanism by which gemcabene lowers LDL-C and, more importantly, whether there is a common element in the mechanism with statins, are largely unknown. Very little is known on whether the mechanism by which CETP inhibitors reduce LDL-C is shared with those known for statins, and understanding lipoprotein metabolism may explain this lack of an additive effect for anacetrapib and simvastatin. Recently, it was reported that whereas subjects treated with torcetrapib alone demonstrated an enhanced rate of LDL apoB100 catabolism, in subjects pretreated with atorvastatin, in which LDL apoB100 catabolism was already enhanced as a result of atorvastatin treatment, there was a reduced LDL apoB100 production rate [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b18" rid="b18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511242" role="button" aria-expanded="false" aria-haspopup="true">18</a>]. Because CETP transfers triglycerides from triglycerides to LDL in exchange for cholesteryl ester, inhibition of CETP could have additional effects on the metabolism of Apo B-containing lipoproteins that may not be singularly related to exchange of lipids with HDL. It is not known whether anacetrapib would behave differently from torcetrapib with regard to lipoprotein metabolism, and this is currently being investigated. These results appear to suggest, at least for torcetrapib, that there may be a pharmacologically shared mechanism of LDL-C lowering, which presumably might explain the less than additive LDL-C-lowering effects observed with anacetrapib and simvastatin (current study) or with atorvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>].</p><p id="__p35">Although anacetrapib appears to have less than additive lipid-altering effects with atorvastatin [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>] and simvastatin (present study), the lipid-altering effects were anacetrapib dose dependent based on published dose-range studies with anacetrapib [[<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b5" rid="b5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_171511251" role="button" aria-expanded="false" aria-haspopup="true">5</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7" rid="b7" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. The incremental effects with anacetrapib with a statin and influence on residual cardiovascular risk warrant further study.</p><p id="__p36" class="p p-last">There appears to be no clinically meaningful effect of anacetrapib on the pharmacokinetics of simvastatin. When co-administered with simvastatin, anacetrapib appeared to exhibit incremental LDL-C-and Apo B-lowering efficacy. Co-administration of anacetrapib and simvastatin was well tolerated.</p></div><div id="__sec16" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-17"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-18">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec16title">Competing interests</h2><!--/article/back/sec/--><p id="__p37" class="p p-first">R.K., A.G., B.J., S.S.K., J.C. and J.A.W. are employees of Merck &amp; Co., Inc., and may own stock or hold stock options in the company.</p><p id="__p38" class="p p-last">This study was funded by Merck &amp; Co., Inc. The authors acknowledge the assistance of Marissa Fallon and Stefan Zajic in pharmacokinetic calculations, the assistance of Deborah Miksch during the conduct of this study, the assistance of Rita Chiou and Jin Zhang in outsourcing of the simvastatin assay, and the assistance of Josee Cote at the conclusion of the study.</p></div><div id="__sec17" class="tsec bk-sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-19"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-20">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec17title">Supporting Information</h2><!--/article/back/sec/--><p id="__p39" class="p p-first">Additional Supporting Information may be found in the online version of this article:</p><p id="__p40">Table S1</p><div class="sec suppmat" id="SD1"><div class="sup-box half_rhythm" id="N0x1e5f660N0x2348e80"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/bin/bcp0067-0520-SD1.doc">Click here to view.</a><sup>(35K, doc)</sup></div></div><p id="__p41">Summary statistics for blood pressure</p><p id="__p42" class="p p-last">Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.</p></div><div id="__ref-listid492399" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-21"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-22">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ref-listid492399title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1">1. <span class="citation">O'Neill EA, Sparrow CP, Chen Y, Eveland S, Frantz-Wattley B, Milot D, Sinclair PJ, Ali A, Lu Z, Smith CJ, Taylor G, Thompson CF, Anderson MS, Cumiskey A, Rosa R, Strain J, Peterson LB. Identification and characterization of anacetrapib (MK-0859): a novel CETP inhibitor.  abstract]. XVI Int Symp Drugs Affect Lipid Metab. New York, NY, 2007.</span></div><div class="ref-cit-blk half_rhythm" id="b2">2. <span class="citation">Forrest MJ, Bloomfield D, Briscoe RJ, Brown PN, Cumiskey A-M, Ehrhart J, Hershey JC, Keller WJ, Ma X, McPherson HE, Messina E, Peterson LB, Sharif-Rodriquez W, Siegel PS, Sinclair PJ, Sparrow CP, Stevenson AS, Sun SY, Tsai C, Vargas H, Walker M, West SH, White V, Woltmann RF. Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by an increase in circulating aldosterone levels. <span><span class="ref-journal">Br J Pharmacol. </span>2008;<span class="ref-vol">154</span>:146573.</span> abstract. <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440088/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18536749" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3">3. <span class="citation">Krishna R, Bergman A, Chen J, Cote J, Van Hoydonck P, Chavez-Eng C, Lutz R, Laethem T, Van Dyck K, Hilliard D, Laterza O, Snyder K, Jin B, Bloomfield DM, De Smet M, Van Bortel L, Gottesdiener K, Wagner JA. Pharmacokinetics and pharmacodynamics of single doses of MK-0859, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.  abstract]. XVI Int Symp Drugs Affect Lipid Metab. New York, NY, 2007.</span></div><div class="ref-cit-blk half_rhythm" id="b4">4. <span class="citation">Krishna R, Bergman A, Jin B, Fallon M, Cote J, Van Hoydonck P, Laethem T, Gendrano IN, Van Dyck K, Hilliard D, Laterza O, Snyder K, Chavez-Eng C, Lutz R, Chen J, Bloomfield DM, De Smet M, Van Bortel L, Gutierrez M, Al-Huniti N, Dykstra K, Gottesdiener KM, Wagner JA. Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) inhibitor, in healthy subjects. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2008;<span class="ref-vol">84</span>:67983.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18580870" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5">5. <span class="citation">Krishna R, Anderson MS, Bergman A, Jin B, Fallon M, Cote J, Rosko K, Chavez-Eng C, Lutz R, Bloomfield DM, Gutierrez M, Doherty J, Bieberdorf F, Chodakewitz J, Gottesdiener K, Wagner JA. Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies. <span><span class="ref-journal">Lancet. </span>2007;<span class="ref-vol">370</span>:19071914.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18068514" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b6">6. <span class="citation">Bergman A, Dykstra K, Al-Huniti N, Fallon M, Lutz R, Chavez-Eng C, Jin B, Hartford A, Cote J, Hilliard D, Laethem T, Van Hoydonck P, Snyder K, Van Dyck K, Stone J, Lasseter KC, Van Bortel L, Wagner J, Krishna R. Optimizing dose selection using population PK/PD modeling and simulation for the CETP inhibitor anacetrapib (MK-0859) in healthy subjects.  abstract]. American Association of Pharmaceutical Scientists Annual Meeting, Anaheim, CA, 2007.</span></div><div class="ref-cit-blk half_rhythm" id="b7">7. <span class="citation">Bloomfield DM, Carlson G, Sapre A, Tribble D, McKenney JM, Littlejohn TW, Sisk CM, Mitchel YB. Efficacy and safety of the CETP inhibitor MK-0859 in dyslipidemic patients.  abstract]. XVI Int Symp Drugs Affect Lipid Metab (DALM). New York, NY, 2007.</span></div><div class="ref-cit-blk half_rhythm" id="b8">8. <span class="citation">Krishna R, Bergman AJ, Jin B, Garg A, Roadcap BA, Chiou RH, Dru JD, Cote J, Laethem T, Vets E, Avery P, Gottesdiener KM, Wagner JA. Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. <span><span class="ref-journal">J Clin Pharmacol. </span>2009;<span class="ref-vol">49</span>:807.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19004846" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9">9. <span class="citation">Purves R. Validation of a method for the determination of simvastatin and simvastatin acid in human plasma by HPLC with MS/MS detection.  Method validation report. Covance Study No 2100-823, Covance Laboratories, Madison, Ohio.</span></div><div class="ref-cit-blk half_rhythm" id="b10">10. <span class="citation">Merck &amp; Co., Inc. <span class="ref-journal">Zocor (Simvastatin) Product Circular.</span> Whitehouse Station, NJ: Merck &amp; Co., Inc; 2004. </span></div><div class="ref-cit-blk half_rhythm" id="b11">11. <span class="citation">Mlgaard J, Lundh BL, van Schenck H, Olsson AG. Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolemia. <span><span class="ref-journal">Atherosclerosis. </span>1991;<span class="ref-vol">91</span>:S218.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1789813" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12">12. <span class="citation">Kantola T, Kivist KT, Neuvonen PT. Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. <span><span class="ref-journal">Clin Pharmacol Ther. </span>1998;<span class="ref-vol">64</span>:17782.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9728898" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13">13. <span class="citation">Gruer PJK, Vega JM, Mercuri MF, Dobrinska MR, Tobert JA. Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin. <span><span class="ref-journal">Am J Cardiol. </span>1999;<span class="ref-vol">84</span>:8115.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10513779" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14">14. <span class="citation">Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra V, Affrime MB. Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2002;<span class="ref-vol">54</span>:30919.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874429/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12236852" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15">15. <span class="citation">Thuren T, Longcore A, Powell C. Torcetrapib combined with atorvastatin raises HDL-C, lowers LDL-C, and is well tolerated: results from a phase 2 dose-ranging clinical trial. <span><span class="ref-journal">Circulation. </span>2005;<span class="ref-vol">112</span>(17) Suppl.:II-179.</span></span></div><div class="ref-cit-blk half_rhythm" id="b16">16. <span class="citation">Mandema JW, Hermann D, Wang W, Sheiner T, Milad M, Bakker-Arkema R, Hartman D. Model-based development of gemcabene, a new lipid-altering agent. <span><span class="ref-journal">AAPS J. </span>2005;<span class="ref-vol">7</span>:E51322.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751254/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16353929" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b17">17. <span class="citation">Mlgaard J, von Schenck H, Olsson AG. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia. <span><span class="ref-journal">Eur J Clin Pharmacol. </span>1989;<span class="ref-vol">36</span>:45560.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/2502417" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b18">18. <span class="citation">Millar JS, Brousseau M, Diffenderfer MR, Hugh P, Barrett R, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio A, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>2006;<span class="ref-vol">26</span>:13506.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16574893" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#__abstractid770149title">Abstract</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#__sec7title">Introduction</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#__sec8title">Methods</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#__sec14title">Results</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#__sec15title">Discussion</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#__sec16title">Competing interests</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#__sec17title">Supporting Information</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#__ref-listid492399title">REFERENCES</a></li></ul></div></div><!--post-content--><hr class="whole_rhythm no_bottom_margin"><div class="courtesy-note no_margin small">Articles from <span class="acknowledgment-journal-title">British Journal of Clinical Pharmacology</span> are provided here courtesy of <strong>British Pharmacological Society</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="try-button"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/?report=reader"><img src="./PMC2686068_files/3838809" alt="PubReader format: click here to try"></a></div><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/epub/">ePub (beta)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/pdf/bcp0067-0520.pdf">PDF (557K)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" data-citationid="PMC2686068" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2686068%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC2686068_files/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2686068%2F&amp;text=Assessment%20of%20a%20pharmacokinetic%20and%20pharmacodynamic%20interaction%20between%20simvastatin%20and%20anacetrapib%2C%20a%20potent%20cholesteryl%20ester%20transfer%20protein%20(CETP)%20inhibitor%2C%20in%20healthy%20subjects" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC2686068_files/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2686068%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC2686068_files/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="19552746" data-aiid="2686068" data-aid="2686068" data-iid="179035" data-domainid="279" data-domain="brjclinpharm" data-accid="PMC2686068" data-md5="6c49e2a575c07a8460a5f2337a0fc7be">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-25" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-25" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input type="hidden" name="absid" id="absid" value="2686068"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="http://www.ncbi.nlm.nih.gov/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:&#39;#favUL&#39;,starExists:true,createCollectionUrl:&#39;#&#39;,manageCollectionsUrl:&#39;/myncbi/collections/&#39;"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="http://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input type="submit" class="button_apply" name="addtocollection" value="1"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-27" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-27" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/22243494" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.</a><span class="source">[Br J Clin Pharmacol. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-29" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Krishna R, Stypinski D, Ali M, Garg A, Cote J, Maes A, Degroot B, Liu Y, Li S, Connolly SM, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Br J Clin Pharmacol. 2012 Jul; 74(1):116-24. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/19004846" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers.</a><span class="source">[J Clin Pharmacol. 2009]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-31" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Krishna R, Bergman AJ, Jin B, Garg A, Roadcap B, Chiou R, Dru J, Cote J, Laethem T, Wang RW, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Pharmacol. 2009 Jan; 49(1):80-7. Epub 2008 Nov 11.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/16490579" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.</a><span class="source">[Clin Ther. 2006]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-33" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Penn R, Williams RX 3rd, Guha-Ray DK, Sawyers WG, Braun SL, Rains KT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Ther. 2006 Jan; 28(1):45-54. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/19705341" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Anacetrapib, a cholesterol ester transfer protein (CETP) inhibitor for the treatment of atherosclerosis.</a><span class="source">[Curr Opin Investig Drugs. 2009]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-35" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Masson D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Curr Opin Investig Drugs. 2009 Sep; 10(9):980-7. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/22661899" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.</a><span class="source">[Vasc Health Risk Manag. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-37" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shinkai H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Vasc Health Risk Manag. 2012; 8:323-31. Epub 2012 May 15.</em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=19552746&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=19552746&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-39" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-39" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720705/" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Future of Cholesterol Ester Transfer Protein (CETP) inhibitors: A Pharmacological Perspective</a><span class="source">[Clinical pharmacokinetics. 2013]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-41" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mohammadpour AH, Akhlaghi F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clinical pharmacokinetics. 2013 Aug; 52(8)615-626</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460676/" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib</a><span class="source">[Drug Design, Development and T...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-43" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Goldberg AS, Hegele RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drug Design, Development and Therapy. 2012 Sep 24; 6251-259</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430392/" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib</a><span class="source">[Vascular Health and Risk Manag...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-45" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miyares MA, Davis K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Vascular Health and Risk Management. 2012 Aug 23; 8483-493</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394135/" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects</a><span class="source">[British Journal of Clinical Ph...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-47" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Krishna R, Stypinski D, Ali M, Garg A, Cote J, Maes A, DeGroot B, Liu Y, Li S, Connolly SM, Wagner JA, Stoch SA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">British Journal of Clinical Pharmacology. 2012 Jan 13; 74(1)116-124</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014066/" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Lack of clinically relevant drugdrug interactions when dalcetrapib is co-administered with ezetimibe</a><span class="source">[British Journal of Clinical Ph...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-49" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Derks M, Abt M, Phelan M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">British Journal of Clinical Pharmacology. 2010 Dec; 70(6)825-833</em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/citedby/" ref="reftype=relart&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-51" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-51" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=2686068" ref="reftype=Compound&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-53" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=2686068" ref="reftype=MedGen&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-55" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/19552746/" ref="reftype=PubMed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-57" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=2686068" ref="reftype=Substance&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-59" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-61" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-61" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState(&#39;ClearHT&#39;)">Clear</a><a href="javascript:historyDisplayState(&#39;HTOff&#39;)" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState(&#39;HTOn&#39;)" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c277b04fcfad59176aad9">Assessment of a pharmacokinetic and pharmacodynamic interaction between simvasta...</a><div class="ralinkpop offscreen_noflow">Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects<div class="brieflinkpopdesc">British Journal of Clinical Pharmacology. 2009 May; 67(5)520</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=2" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2777f0c03b798175749b">PMC2686068 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2766f0c03b7981757178">Tamoxifen's protection against breast cancer recurrence is not reduced by concur...</a><div class="ralinkpop offscreen_noflow">Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram<div class="brieflinkpopdesc">British Journal of Cancer. 2008 Aug 12; 99(4)616</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=4" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2763f0c03b79817570e4">PMC2527838 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c275004fcfad59176a355">Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects</a><div class="ralinkpop offscreen_noflow">Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects<div class="brieflinkpopdesc">British Journal of Clinical Pharmacology. 2004 Feb; 57(2)181</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState(&#39;HTOn&#39;)">Turn recording back on</a></p>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p10" name="crb--__p10" rid="__p10" style="position: absolute; visibility: visible; width: 370px; top: 1710px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-63"><ul><li class="two_line" reference_id="b8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19004846/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers.</a><span class="one_line_source">[J Clin Pharmacol.  2009]</span><div class="alt-note">
<div class="authors">Krishna R, Bergman AJ, Jin B, Garg A, Roadcap B, Chiou R, Dru J, Cote J, Laethem T, Wang RW, Didolkar V, Vets E, Gottesdiener K, Wagner JA</div>
<div class="citation">J Clin Pharmacol. 2009 Jan; 49(1):80-7.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p11" name="crb--__p11" rid="__p11" style="position: absolute; visibility: visible; width: 370px; top: 1784px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-64"><ul><li class="two_line" reference_id="b8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19004846/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers.</a><span class="one_line_source">[J Clin Pharmacol.  2009]</span><div class="alt-note">
<div class="authors">Krishna R, Bergman AJ, Jin B, Garg A, Roadcap B, Chiou R, Dru J, Cote J, Laethem T, Wang RW, Didolkar V, Vets E, Gottesdiener K, Wagner JA</div>
<div class="citation">J Clin Pharmacol. 2009 Jan; 49(1):80-7.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p30" name="crb--__p30" rid="__p30" style="position: absolute; visibility: visible; width: 370px; top: 4177px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-65"><ul>
<li class="two_line" reference_id="b4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18580870/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Krishna R, Bergman AJ, Jin B, Fallon M, Cote J, Van Hoydonck P, Laethem T, Gendrano IN 3rd, Van Dyck K, Hilliard D, Laterza O, Snyder K, Chavez-Eng C, Lutz R, Chen J, Bloomfield DM, De Smet M, Van Bortel LM, Gutierrez M, Al-Huniti N, Dykstra K, Gottesdiener KM, Wagner JA</div>
<div class="citation">Clin Pharmacol Ther. 2008 Dec; 84(6):679-83.</div>
</div>
</li>
<li class="two_line" reference_id="b5">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18068514/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.</a><span class="one_line_source">[Lancet.  2007]</span><div class="alt-note">
<div class="authors">Krishna R, Anderson MS, Bergman AJ, Jin B, Fallon M, Cote J, Rosko K, Chavez-Eng C, Lutz R, Bloomfield DM, Gutierrez M, Doherty J, Bieberdorf F, Chodakewitz J, Gottesdiener KM, Wagner JA</div>
<div class="citation">Lancet. 2007 Dec 8; 370(9603):1907-14.</div>
</div>
</li>
<li class="two_line" reference_id="b11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/1789813/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia.</a><span class="one_line_source">[Atherosclerosis.  1991]</span><div class="alt-note">
<div class="authors">Mlgaard J, Lundh BL, von Schenck H, Olsson AG</div>
<div class="citation">Atherosclerosis. 1991 Dec; 91 Suppl():S21-8.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p31" name="crb--__p31" rid="__p31" style="position: absolute; visibility: visible; width: 370px; top: 4608px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-66"><ul>
<li class="two_line" reference_id="b12">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9728898/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations.</a><span class="one_line_source">[Clin Pharmacol Ther.  1998]</span><div class="alt-note">
<div class="authors">Kantola T, Kivist KT, Neuvonen PJ</div>
<div class="citation">Clin Pharmacol Ther. 1998 Aug; 64(2):177-82.</div>
</div>
</li>
<li class="two_line" reference_id="b14">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12236852/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.</a><span class="one_line_source">[Br J Clin Pharmacol.  2002]</span><div class="alt-note">
<div class="authors">Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB</div>
<div class="citation">Br J Clin Pharmacol. 2002 Sep; 54(3):309-19.</div>
</div>
</li>
<li class="two_line" reference_id="b8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19004846/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers.</a><span class="one_line_source">[J Clin Pharmacol.  2009]</span><div class="alt-note">
<div class="authors">Krishna R, Bergman AJ, Jin B, Garg A, Roadcap B, Chiou R, Dru J, Cote J, Laethem T, Wang RW, Didolkar V, Vets E, Gottesdiener K, Wagner JA</div>
<div class="citation">J Clin Pharmacol. 2009 Jan; 49(1):80-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p32" name="crb--__p32" rid="__p32" style="position: absolute; visibility: visible; width: 370px; top: 4745px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-67"><ul>
<li class="two_line" reference_id="b4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18580870/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Krishna R, Bergman AJ, Jin B, Fallon M, Cote J, Van Hoydonck P, Laethem T, Gendrano IN 3rd, Van Dyck K, Hilliard D, Laterza O, Snyder K, Chavez-Eng C, Lutz R, Chen J, Bloomfield DM, De Smet M, Van Bortel LM, Gutierrez M, Al-Huniti N, Dykstra K, Gottesdiener KM, Wagner JA</div>
<div class="citation">Clin Pharmacol Ther. 2008 Dec; 84(6):679-83.</div>
</div>
</li>
<li class="two_line" reference_id="b5">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18068514/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.</a><span class="one_line_source">[Lancet.  2007]</span><div class="alt-note">
<div class="authors">Krishna R, Anderson MS, Bergman AJ, Jin B, Fallon M, Cote J, Rosko K, Chavez-Eng C, Lutz R, Bloomfield DM, Gutierrez M, Doherty J, Bieberdorf F, Chodakewitz J, Gottesdiener KM, Wagner JA</div>
<div class="citation">Lancet. 2007 Dec 8; 370(9603):1907-14.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p34" name="crb--__p34" rid="__p34" style="position: absolute; visibility: visible; width: 370px; top: 5524px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-68"><ul>
<li class="two_line" reference_id="b16">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16353929/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Model-based development of gemcabene, a new lipid-altering agent.</a><span class="one_line_source">[AAPS J.  2005]</span><div class="alt-note">
<div class="authors">Mandema JW, Hermann D, Wang W, Sheiner T, Milad M, Bakker-Arkema R, Hartman D</div>
<div class="citation">AAPS J. 2005 Oct 7; 7(3):E513-22.</div>
</div>
</li>
<li class="two_line" reference_id="b14">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12236852/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.</a><span class="one_line_source">[Br J Clin Pharmacol.  2002]</span><div class="alt-note">
<div class="authors">Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB</div>
<div class="citation">Br J Clin Pharmacol. 2002 Sep; 54(3):309-19.</div>
</div>
</li>
<li class="two_line" reference_id="b11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/1789813/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia.</a><span class="one_line_source">[Atherosclerosis.  1991]</span><div class="alt-note">
<div class="authors">Mlgaard J, Lundh BL, von Schenck H, Olsson AG</div>
<div class="citation">Atherosclerosis. 1991 Dec; 91 Suppl():S21-8.</div>
</div>
</li>
<li class="two_line" reference_id="b17">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/2502417/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.</a><span class="one_line_source">[Eur J Clin Pharmacol.  1989]</span><div class="alt-note">
<div class="authors">Mlgaard J, von Schenck H, Olsson AG</div>
<div class="citation">Eur J Clin Pharmacol. 1989; 36(5):455-60.</div>
</div>
</li>
<li class="two_line" reference_id="b18">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16574893/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.</a><span class="one_line_source">[Arterioscler Thromb Vasc Biol.  2006]</span><div class="alt-note">
<div class="authors">Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ</div>
<div class="citation">Arterioscler Thromb Vasc Biol. 2006 Jun; 26(6):1350-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p35" name="crb--__p35" rid="__p35" style="position: absolute; visibility: visible; width: 370px; top: 5997px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-69"><ul><li class="two_line" reference_id="b5">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18068514/" ref="reftype=pubmed&amp;article-id=2686068&amp;issue-id=179035&amp;journal-id=279&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.</a><span class="one_line_source">[Lancet.  2007]</span><div class="alt-note">
<div class="authors">Krishna R, Anderson MS, Bergman AJ, Jin B, Fallon M, Cote J, Rosko K, Chavez-Eng C, Lutz R, Bloomfield DM, Gutierrez M, Doherty J, Bieberdorf F, Chodakewitz J, Gottesdiener KM, Wagner JA</div>
<div class="citation">Lancet. 2007 Dec 8; 370(9603):1907-14.</div>
</div>
</li></ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="./PMC2686068_files/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-b1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">1. <span class="citation">O'Neill EA, Sparrow CP, Chen Y, Eveland S, Frantz-Wattley B, Milot D, Sinclair PJ, Ali A, Lu Z, Smith CJ, Taylor G, Thompson CF, Anderson MS, Cumiskey A, Rosa R, Strain J, Peterson LB. Identification and characterization of anacetrapib (MK-0859): a novel CETP inhibitor.  abstract]. XVI Int Symp Drugs Affect Lipid Metab. New York, NY, 2007.</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b1">Ref list</a>]</div><div id="body-link-popper-b8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers.<div class="authors">Krishna R, Bergman AJ, Jin B, Garg A, Roadcap B, Chiou R, Dru J, Cote J, Laethem T, Wang RW, Didolkar V, Vets E, Gottesdiener K, Wagner JA</div><div class="citation">J Clin Pharmacol. 2009 Jan; 49(1):80-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19004846/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b8">Ref list</a>]</p></div><div id="body-link-popper-b9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">9. <span class="citation">Purves R. Validation of a method for the determination of simvastatin and simvastatin acid in human plasma by HPLC with MS/MS detection.  Method validation report. Covance Study No 2100-823, Covance Laboratories, Madison, Ohio.</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b9">Ref list</a>]</div><div id="body-link-popper-b10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">10. <span class="citation">Merck &amp; Co., Inc. <span class="ref-journal">Zocor (Simvastatin) Product Circular.</span> Whitehouse Station, NJ: Merck &amp; Co., Inc; 2004. </span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b10">Ref list</a>]</div><div id="body-link-popper-b4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.<div class="authors">Krishna R, Bergman AJ, Jin B, Fallon M, Cote J, Van Hoydonck P, Laethem T, Gendrano IN 3rd, Van Dyck K, Hilliard D, Laterza O, Snyder K, Chavez-Eng C, Lutz R, Chen J, Bloomfield DM, De Smet M, Van Bortel LM, Gutierrez M, Al-Huniti N, Dykstra K, Gottesdiener KM, Wagner JA</div><div class="citation">Clin Pharmacol Ther. 2008 Dec; 84(6):679-83.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18580870/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b4">Ref list</a>]</p></div><div id="body-link-popper-b5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.<div class="authors">Krishna R, Anderson MS, Bergman AJ, Jin B, Fallon M, Cote J, Rosko K, Chavez-Eng C, Lutz R, Bloomfield DM, Gutierrez M, Doherty J, Bieberdorf F, Chodakewitz J, Gottesdiener KM, Wagner JA</div><div class="citation">Lancet. 2007 Dec 8; 370(9603):1907-14.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18068514/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b5">Ref list</a>]</p></div><div id="body-link-popper-b7" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">7. <span class="citation">Bloomfield DM, Carlson G, Sapre A, Tribble D, McKenney JM, Littlejohn TW, Sisk CM, Mitchel YB. Efficacy and safety of the CETP inhibitor MK-0859 in dyslipidemic patients.  abstract]. XVI Int Symp Drugs Affect Lipid Metab (DALM). New York, NY, 2007.</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b7">Ref list</a>]</div><div id="body-link-popper-b3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">3. <span class="citation">Krishna R, Bergman A, Chen J, Cote J, Van Hoydonck P, Chavez-Eng C, Lutz R, Laethem T, Van Dyck K, Hilliard D, Laterza O, Snyder K, Jin B, Bloomfield DM, De Smet M, Van Bortel L, Gottesdiener K, Wagner JA. Pharmacokinetics and pharmacodynamics of single doses of MK-0859, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.  abstract]. XVI Int Symp Drugs Affect Lipid Metab. New York, NY, 2007.</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b3">Ref list</a>]</div><div id="body-link-popper-b11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia.<div class="authors">Mlgaard J, Lundh BL, von Schenck H, Olsson AG</div><div class="citation">Atherosclerosis. 1991 Dec; 91 Suppl():S21-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1789813/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b11">Ref list</a>]</p></div><div id="body-link-popper-b12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations.<div class="authors">Kantola T, Kivist KT, Neuvonen PJ</div><div class="citation">Clin Pharmacol Ther. 1998 Aug; 64(2):177-82.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9728898/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b12">Ref list</a>]</p></div><div id="body-link-popper-b14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.<div class="authors">Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB</div><div class="citation">Br J Clin Pharmacol. 2002 Sep; 54(3):309-19.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12236852/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b14">Ref list</a>]</p></div><div id="body-link-popper-b15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">15. <span class="citation">Thuren T, Longcore A, Powell C. Torcetrapib combined with atorvastatin raises HDL-C, lowers LDL-C, and is well tolerated: results from a phase 2 dose-ranging clinical trial. <span><span class="ref-journal">Circulation. </span>2005;<span class="ref-vol">112</span>(17) Suppl.:II-179.</span></span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b15">Ref list</a>]</div><div id="body-link-popper-b16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Model-based development of gemcabene, a new lipid-altering agent.<div class="authors">Mandema JW, Hermann D, Wang W, Sheiner T, Milad M, Bakker-Arkema R, Hartman D</div><div class="citation">AAPS J. 2005 Oct 7; 7(3):E513-22.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16353929/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b16">Ref list</a>]</p></div><div id="body-link-popper-b17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.<div class="authors">Mlgaard J, von Schenck H, Olsson AG</div><div class="citation">Eur J Clin Pharmacol. 1989; 36(5):455-60.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/2502417/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b17">Ref list</a>]</p></div><div id="body-link-popper-b18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.<div class="authors">Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ</div><div class="citation">Arterioscler Thromb Vasc Biol. 2006 Jun; 26(6):1350-6.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16574893/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#b18">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <div class="breadcrumbs">You are here: 
            <span id="breadcrumb_text"><a href="http://www.ncbi.nlm.nih.gov/guide/">NCBI</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central (PMC)</a></span></div>
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="http://www.ncbi.nlm.nih.gov/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-06-23T14:16:27-04:00&amp;Host=ptpmc202">Write to the Help Desk</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="./PMC2686068_files/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="http://www.nlm.nih.gov/" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="http://www.nih.gov/" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="http://www.dhhs.gov/" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="http://www.usa.gov/" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            
            <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Copyright</a> | <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html#disclaimer">Disclaimer</a> |
            <a href="http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a> | 
            <a href="http://www.ncbi.nlm.nih.gov/guide/browsers/">Browsers</a> | <a href="http://www.nlm.nih.gov/accessibility.html">Accessibility</a> | <a href="http://www.ncbi.nlm.nih.gov/About/glance/contact_info.html">Contact</a>
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="http://www.ncbi.nlm.nih.gov/">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url"><a href="http://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
        </div>
    </div>
    <script type="text/javascript" src="./PMC2686068_files/InstrumentPageStarterJS.js"> </script>    
    <script type="text/javascript" src="./PMC2686068_files/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div><div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 63.5938px; left: 408.188px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: none;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686068/#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: none;">Turn off</a></div></div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=brjclinpharm&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC2686068/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC7E8376854741_0014SID /projects/PMC/PMCViewer@4.35 ptpmc202 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->

<script type="text/javascript" src="./PMC2686068_files/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1" style="display: none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><ul class="print-log"><li></li></ul><div class="ui-ncbipopper-arrow-image ui-ncbipopper-arrow-right" style="display: none; top: -100px; left: -100px; opacity: 1;">&nbsp;</div></body></html>